ASX BRIEFS

Andrew Musgrave
  • 5.0 (2)
  • INVESTING
  • UPDATED DAILY

Welcome to 'ASX BRIEFS,' the definitive podcast for enthusiasts, investors, and professionals keen on staying ahead of the curve in the Australian Stock Exchange (ASX). Hosted by Andrew Musgrave, 'ASX BRIEFS' delves deep into the heart of Australia's financial markets, bringing you insightful conversations with the minds shaping the future of investing down under. Each episode, join Andrew as he interviews a diverse lineup of fund managers, executives, and industry insiders, offering you a unique blend of expert analysis, strategic insights, and the latest trends affecting the ASX. Whether you're a seasoned investor or just starting out, 'ASX BRIEFS' is your go-to source for comprehensive updates and thought-provoking discussions designed to inform, inspire, and empower your investment journey. Tune in to 'ASX BRIEFS' and take the pulse of Australia's financial markets right at your fingertips.

  1. 1 DAY AGO

    FIREBIRD METALS LTD (FRB) - Australia Can Build A Non-China Battery Materials Alternative

    Send us Fan Mail The EV battery revolution isn’t just about who sells the most cars, it’s about who controls the materials that make batteries cheaper, safer, and easier to source. I’m joined by Ron Mitchell, CEO of Firebird Metals, to talk about a different kind of advantage: taking manganese concentrate and turning it into high value battery materials in a single integrated processing circuit, rather than shipping intermediates across a fragmented, multi-country supply chain. If you care about Australian critical minerals, battery materials, and the future of energy storage, this conversation is packed with practical detail. We walk through Firebird’s “concentrate to cathode” approach, including high purity manganese sulphate production and why that product is such a strategic pinch point outside China. Ron explains why manganese is attracting serious attention as battery makers chase the holy grail of lower dollars per kilowatt hour, and how LMFP (lithium manganese iron phosphate) is emerging as a compelling evolution of LFP chemistry. We also dig into what “lithium manganese rich” (LMR) means, why it can reduce reliance on high nickel cathodes, and why Western OEMs are watching closely. From there, we get into the moat-building pieces: Firebird’s exclusive LMFP patent licence through to May 2045, the commercialisation pathway that leans capital-light through partnering and licensing, and the importance of proving the technology in a Western setting via a demonstration plant near the Perth CBD. Ron also shares what it means to secure an ARENA Battery Breakthrough Initiative grant, and what shareholders should watch for across 2026 as equipment lands, commissioning ramps up, and new IP is lodged. Subscribe for more conversations on ASX-listed innovators, share this with a mate who follows EVs and critical minerals, and leave a review to help others find the show. What do you think matters more right now: battery chemistry breakthroughs or supply chain sovereignty?

    19 min

  2. 2 DAYS AGO

    ROCKETDNA LTD (RKT) - Autonomous Drones In Mining

    Send us Fan Mail Mine sites are drowning in tasks that are repetitive, risky, and time-heavy, yet the real value sits on the other side of the work: clean data that helps people make faster calls. We chat with Chris Clark, Managing Director and CEO of RocketDNA Limited, about how AI-driven autonomous drones are taking on aerial surveying, security and surveillance, and asset inspection for Tier 1 mining customers across Australia and Africa and what that means when the output is trusted enough to drive day-to-day decisions. We break down RocketDNA’s latest momentum, including revenue growth and the milestone of first positive operating cash flow, and why management keeps coming back to recurring revenue as the foundation for a scalable ASX microcap business. Chris explains how the xBot® solution brings together autonomous drone hardware, remote operations, and two key software layers: the SiteTube visualisation platform and Skylink®, RocketDNA’s proprietary operating system for managing autonomous drone fleets at enterprise level. Skylink® is where the conversation gets practical: access control, scheduling, demand planning, maintenance oversight, and the jump from running a handful of drones to operating fleets across multiple sites. We also dig into the leading indicators that show whether a platform is becoming “sticky” including flight mission growth and active software users and why land-and-expand economics can beat constant greenfield chasing when customers keep ordering more units to meet demand. If you care about autonomous drone technology, mining digitisation, and the shift from hardware projects to software-backed recurring revenue, this one is for you. Subscribe, share it with a mate in resources or tech, and leave us a review, then tell us: where do you think autonomous drones deliver the biggest productivity win first?

    14 min

  3. 3 DAYS AGO

    ONE CLICK GROUP LTD (1CG) - How One Click Group Builds A One Stop Financial Life Platform

    Send us Fan Mail A fintech business can grow fast, but growing efficiently is the real test. We sit down with Mark Waller, Managing Director of One Click Group Limited, for a clear update on how One Click Life is scaling as a financial life admin app for Australians. Mark walks us through the company’s FY2025 performance, including record revenue of $6.1 million and its first underlying EBITDA profit, and why that profitability milestone changes what’s possible when it comes to funding marketing and expanding the product suite. We also get practical about the operating model: how One Click keeps fixed operating costs largely steady while the user base climbs, and how a shift toward organic growth channels is lowering user acquisition costs. Mark explains what’s driving engagement outside the traditional tax season, and why adding more services creates multiple paths to market instead of relying on a single product cycle. If you follow ASX fintech stocks, unit economics, or scalable software platforms, there’s plenty here to consider. From there we explore product expansion across online tax returns, wills, insurance, lending, and the Little Money cash advance product, designed to meet year round demand for short term liquidity. We also unpack One Click Super, built and awaiting trustee approval, with a focus on helping younger users consolidate and manage superannuation in one place. To finish, Mark shares what success looks like through 2026 from both a shareholder and customer lens, and how automation and API integration help deliver a smoother experience at scale. If you found value here, subscribe, share the episode with a mate, and leave a review. What would you most want to manage in one app: tax, super, or day to day cash flow?

    11 min

  4. 5 DAYS AGO

    GREENTECH METALS LTD (GRE) - A Historic Reef And Mine Data Could Re-Rate GreenTech Metals

    Send us Fan Mail A thin, high-grade reef can be impressive on paper, but it can also be hard to mine at scale. That’s why we sit down with GreenTech Metals CEO James Rattenbury to talk about a different way to view the Munni Munni platinum group metals system in Western Australia’s West Pilbara: not just the reef, but the wider mineralised zones around it that bring copper and nickel into the story. We walk through what Green Tech Metals is building across a dominant regional footprint, anchored by two projects only about 10 kilometres apart: Munni Munni (PGE with base metals potential) and Whundo (a high-grade copper-zinc VMS asset with overlooked gold). James explains why commodity prices, mining methods, and development benchmarks have shifted since earlier studies, and how that changes what “historic” data can be worth today. We also unpack the practical work underway, including drilling, resampling preserved legacy core, and QA/QC designed to support a JORC 2012 mineral resource estimate targeted for the June quarter. From there, we look ahead to the 2026 catalyst timeline: Money Money’s re-estimated resource in late June, Whundo’s update by August, drilling news flow from June, and the metallurgical test work needed to confirm a simple concentrate pathway with meaningful PGE credits. If you follow ASX mining, critical minerals, platinum group metals, copper, nickel, and WA exploration, this conversation maps the milestones that could drive a re-rate. Subscribe for more ASX Briefs, share this episode with a mate who follows resources, and leave a review so more listeners can find the show.

    12 min

  5. 8 MAY

    IMPACT MINERALS LTD (IPT) - High-Purity Alumina And The Tech Supply Chain

    Send us Fan Mail One obscure material is quietly doing heavy lifting across the modern economy: high purity alumina (HPA). From LED lighting to semiconductor manufacturing to the thermal management challenges inside fast-growing data centres, HPA shows up where heat and chemical stability can’t be left to chance. We sit down with Dr Mike Jones, Managing Director of Impact Minerals, to break down what HPA actually is, why it often becomes artificial sapphire, and why demand growth is catching investors’ attention. We then move from the big picture to the execution plan at the Lake Hope HPA project in Western Australia. Mike explains the practical mining concept on a salt lake, the logistics of moving clay feedstock to Perth, and how the Alluminous processing technology changes the commercial timeline. With a pilot plant progressing from batch toward continuous operation, plus a specialised analytical lab to control impurities, the focus turns to throughput, product consistency, and what it takes to qualify HPA for battery and technology customers, including early test work with a US battery technology company. There’s more optionality on the table too. We unpack a separate flowsheet that targets sulfate of potash (SOP) fertiliser and hydrochloric acid from lake clays around Salmon Gums, and why location matters for both agricultural demand and WA goldfields consumption. Finally, we hit the exploration leverage: high-grade gold and silver results at the Commonwealth VMS project with Kuniko’s drilling ramping up, plus Impact’s large Broken Hill ground position and a compelling magnetotelluric conductor target lined up for future drilling. If you want clear, investor-focused context on Impact Minerals, Lake Hope, HPA processing, SOP fertiliser, Commonwealth drilling, and Broken Hill targeting, hit play, subscribe, share the episode with a mate, and leave a review so more people can find the show.

    15 min

  6. 5 MAY

    BRAZILIAN CRITICAL MINERALS LTD (BCM) - BCM’s Ema Project Explained From Giant Clay Resource To Low Cost In Situ Recovery

    Send us Fan Mail A rare earth project that aims to get to production without crushers, grinding circuits, or a high-cost processing maze gets our attention fast. We sit down again with Andrew Reid, Managing Director of Brazilian Critical Minerals (ASX: BCM), to unpack the Ema ionic adsorption clay deposit in Brazil and why in situ recovery (ISR) could be a genuine cost and schedule advantage for a new Western rare earth supply source. We walk through the latest drilling at Ema and what it says about scale and consistency, alongside the updated mineral resource estimate that underpins the move toward a bankable feasibility study (BFS). Andrew explains the vertical profile many clay deposits show, including enrichment toward the base of the clay, and why Ema’s rare earth mix stands out. We also dig into the commercial reality of rare earths: buyers care about the basket, so discussions around neodymium praseodymium and the presence of heavies like dysprosium and terbium can shape offtake interest and downstream pathways. From there, we get practical on execution risk. Andrew shares where the BFS work is focused now, why BCM is doing capital cost estimation in-country in Brazil, and how sourcing standard equipment locally can support credibility. We also cover BCM’s collaboration agreement with an established ISR operator and the strategic tailwinds Andrew is seeing in US-facing conversations about critical minerals and rare earth supply chain security. If you’re tracking ASX rare earth stocks, Brazilian critical minerals, or the path from feasibility to financing, this is a grounded look at what matters next: BFS completion, permitting, offtake, and bankable project funding. Subscribe, share the episode with a mate who follows rare earths, and leave a review with the key risk or catalyst you think will decide the outcome.

    11 min

  7. 3 MAY

    OPTISCAN IMAGING LTD (OIL) - Real-Time Digital Pathology From A Pen-Sized Scanner

    Send us Fan Mail A pen-sized microscope that can see living tissue in real time sounds like science fiction, but it’s exactly what Optiscan Imaging Limited is building. We welcome back Dr Camile Farah to talk through the company’s confocal laser endomicroscopy platform and why real-time digital pathology could change the way surgery, cancer care, and veterinary medicine make decisions at the point of care. We dig into Optiscan’s latest regulatory milestone: the US FDA dossier submission for InSpecta®, a portable veterinary imaging device designed for clinic and field use. Camile explains why the US market matters so much, why veterinary is a smart entry point with a lower barrier than human healthcare, and how that step can de-risk the broader FDA pathway. If you’re tracking ASX medical device stories, this is a clear look at how regulatory strategy links directly to commercial readiness and revenue timing. From there, we move to human health and a world-first in-human head and neck cancer imaging study at St John of God Murdoch Hospital, combining the InVue® precision surgery device with the InForm® Digital Pathology Platform. The core promise is simple and powerful: help surgeons and pathologists assess margins and tissue features in real time, cutting down the anxious wait for lab reports and reducing the risk of a second surgery. We also cover the partnership with Australian Clinical Labs and how telepathology streaming could enable fast expert reads across distance, much like teleradiology did for medical imaging. If you want practical insight into real-time pathology, telepathology, FDA submissions, and the commercial triggers ahead, listen now. Subscribe to ASX Briefs, share the episode with a colleague, and leave a review with your biggest question about live microscopic imaging in theatre.

    9 min

  8. 29 APR

    FIREBRICK PHARMA LTD (FRE) - Indonesia’s Approval Signals A Commercial Turning Point For Firebrick Pharma

    Send us Fan Mail A product can be ready for the world and still be held back by one thing: how regulators choose to classify it. We sit down again with Dr Peter Molloy, Executive Chairman of Firebrick Pharma, to unpack the company’s shift from R&D to commercial execution and why a single regulatory milestone in Indonesia changes the scale of the Nasodine opportunity. Peter walks us through the origin story that starts with Betadine and leads to Nasodine, a povidone-iodine nasal spray designed to target the viral cause of the common cold using a topical antiseptic approach. We dig into why povidone-iodine remains compelling after decades of use, how low concentrations can still be potent, and why the “no resistance” profile matters when consumers are surrounded by symptom-only OTC options. Just as importantly, we talk about the practical reality for ASX health companies: Australia’s TGA can treat products like Nasodine as a drug, while markets such as Singapore may treat it as an antiseptic, dramatically changing time, cost, and pathway to market. From there, the conversation turns to growth: Indonesia’s approval and its 60 to 65 million middle and upper-middle class consumers, the Philippines as the next potential major approval, and plans to broaden the Nasodine product range. We also cover the business model behind the strategy, including licensing partnerships that reduce manufacturing and marketing burden, recent capital raising, cash burn, and what “runway” looks like in a tough funding environment. If you’re following Firebrick Pharma, Nasodine, or healthcare commercialisation in Southeast Asia, this is the roadmap and the reality check. Subscribe for more ASX Briefs, share this with a mate who follows biotech, and leave a review with your biggest question about Nasodine’s path to global markets.

    17 min
See All (217)

Ratings & Reviews

5
out of 5
2 Ratings

About

Welcome to 'ASX BRIEFS,' the definitive podcast for enthusiasts, investors, and professionals keen on staying ahead of the curve in the Australian Stock Exchange (ASX). Hosted by Andrew Musgrave, 'ASX BRIEFS' delves deep into the heart of Australia's financial markets, bringing you insightful conversations with the minds shaping the future of investing down under. Each episode, join Andrew as he interviews a diverse lineup of fund managers, executives, and industry insiders, offering you a unique blend of expert analysis, strategic insights, and the latest trends affecting the ASX. Whether you're a seasoned investor or just starting out, 'ASX BRIEFS' is your go-to source for comprehensive updates and thought-provoking discussions designed to inform, inspire, and empower your investment journey. Tune in to 'ASX BRIEFS' and take the pulse of Australia's financial markets right at your fingertips.

Information

  • Creator
    Andrew Musgrave
  • Years Active
    2024 - 2026
  • Episodes
    217
  • Rating
    Clean
  • Copyright
    © 2026 ASX BRIEFS
  • Show Website
    ASX BRIEFS

You Might Also Like